OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+23.56%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$796M
AUM Growth
+$796M
(+5.9%)
Cap. Flow
+$22.8M
Cap. Flow
% of AUM
2.86%
Top 10 Holdings %
Top 10 Hldgs %
96.17%
Holding
20
New
3
Increased
5
Reduced
5
Closed
–
Top Buys
| 1 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$14.6M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.3M |
| 3 |
Y-mAbs Therapeutics
YMAB
|
$5.01M |
| 4 |
Biodesix
BDSX
|
$4.19M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$3.39M |
Top Sells
| 1 |
QuidelOrtho
QDEL
|
$6.47M |
| 2 |
AGEN
Agenus
AGEN
|
$4.08M |
| 3 |
AXDX
Accelerate Diagnostics
AXDX
|
$2.16M |
| 4 |
Opko Health
OPK
|
$729K |
| 5 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
$4.56K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
QuidelOrtho
QDEL
$1.95B
| $316M | 39.61% |
1,759,421
-36,041
| -2% | -$6.47M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $184M | 23.07% |
2,148,271
+73,471
| +4% | +$6.3M |
|
|
AWH
3
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $58M | 7.27% |
8,647,094
-680
| -0% | -$4.56K |
|
|
4
Opko Health
OPK
$1.1B
| $52M | 6.52% |
13,171,273
-184,500
| -1% | -$729K |
|
5
Pacific Biosciences
PACB
$393M
| $44.7M | 5.6% |
1,721,459
| – | – |
|
|
AGEN
6
Agenus
AGEN
$133M
| $37.7M | 4.72% |
11,852,372
-1,282,528
| -10% | -$4.08M |
|
|
AXDX
7
DELISTED
Accelerate Diagnostics
AXDX
| $28.9M | 3.62% |
3,806,139
-285,610
| -7% | -$2.16M |
|
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $22.2M | 2.78% |
2,980,870
+455,013
| +18% | +$3.39M |
|
|
DMTK
9
DELISTED
DermTech, Inc. Common Stock
DMTK
| $14.6M | 1.83% |
+450,000
| New | +$14.6M |
|
|
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
| $7.58M | 0.95% |
1,900,000
+200,434
| +12% | +$800K |
|
11
Soleno Therapeutics
SLNO
$3.6B
| $7.08M | 0.89% |
3,670,384
| – | – |
|
|
12
Y-mAbs Therapeutics
YMAB
$388M
| $6.26M | 0.78% |
126,342
+101,130
| +401% | +$5.01M |
|
|
AMRN
13
Amarin Corp
AMRN
$311M
| $5.05M | 0.63% |
1,032,786
+17,285
| +2% | +$84.5K |
|
|
14
Biodesix
BDSX
$62.6M
| $4.19M | 0.53% |
+235,511
| New | +$4.19M |
|
|
MOTS
15
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $3.61M | 0.45% |
3,806,666
| – | – |
|
|
TBIO
16
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.84M | 0.23% |
+100,000
| New | +$1.84M |
|
17
Biogen
BIIB
$19.4B
| $903K | 0.11% |
3,688
| – | – |
|
|
CFRX
18
DELISTED
ContraFect Corporation
CFRX
| $846K | 0.11% |
167,587
| – | – |
|
|
BIOL
19
DELISTED
Biolase, Inc.
BIOL
| $725K | 0.09% |
1,739,100
| – | – |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
0
| – | – |
|